文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

多发性骨髓瘤骨髓微环境。

Multiple myeloma bone marrow niche.

作者信息

Basak Grzegorz Wladyslaw, Srivastava Anand S, Malhotra Rakesh, Carrier Ewa

机构信息

Rebecca and John Moore's Cancer Center, University of California-San Diego, 3855 Health Science Drive, La Jolla, CA 92093-0960, USA.

出版信息

Curr Pharm Biotechnol. 2009 Apr;10(3):345-6. doi: 10.2174/138920109787847493.


DOI:10.2174/138920109787847493
PMID:19355944
Abstract

"Niche" is defined as a specialized regulatory microenvironment, consisting of components which control the fate specification of stem and progenitor cells, as well as maintaining their development by supplying the requisite factors. Bone marrow (BM) niche has a well-organized architecture and is composed of osteoblasts, osteoclasts, bone marrow endothelial cells, stromal cells, adipocytes and extracellular matrix proteins (ECM). These elements play an essential role in the survival, growth and differentiation of diverse lineages of blood cells, but also provide optimal growth environment for multiple hematological malignancies including multiple myeloma (MM). MM is a neoplastic plasma cell disorder which not only resides in BM but also converts it into specialized neoplastic niche. This niche aids the growth and spreading of tumor cells by a complex interplay of cytokines, chemokines, proteolytic enzymes and adhesion molecules. Moreover, the MM BM microenvironment was shown to confer survival and chemoresistance of MM cells to current therapies. However, our knowledge in this field is still in infancy and many details are unknown. Therefore, there is a strong need to further dissect the MM BM niche and understand the process of how the complex interactions with BM milieu influence MM growth, survival and development of resistance to chemotherapy. A better and more detailed understanding of neoplastic MM niche will provide a guiding model for identifying and validating novel targeted therapies directed against MM. Therefore, in the present review, we have focused principally on the basic features, physical structures, and functions of the BM niche and have highlighted its interaction with MM cells.

摘要

“生态位”被定义为一种特殊的调节性微环境,由控制干细胞和祖细胞命运特化的成分组成,并通过提供必要因子来维持它们的发育。骨髓(BM)生态位具有组织良好的结构,由成骨细胞、破骨细胞、骨髓内皮细胞、基质细胞、脂肪细胞和细胞外基质蛋白(ECM)组成。这些成分不仅在不同血细胞谱系的存活、生长和分化中起重要作用,还为包括多发性骨髓瘤(MM)在内的多种血液系统恶性肿瘤提供了最佳生长环境。MM是一种肿瘤性浆细胞疾病,它不仅存在于骨髓中,还将骨髓转化为特殊的肿瘤生态位。这个生态位通过细胞因子、趋化因子、蛋白水解酶和黏附分子的复杂相互作用促进肿瘤细胞的生长和扩散。此外,MM骨髓微环境被证明赋予MM细胞对当前疗法的存活能力和化疗耐药性。然而,我们在这个领域的知识仍处于起步阶段,许多细节尚不清楚。因此,迫切需要进一步剖析MM骨髓生态位,并了解与骨髓微环境的复杂相互作用如何影响MM的生长、存活和化疗耐药性发展的过程。对肿瘤性MM生态位有更好、更详细的了解将为识别和验证针对MM的新型靶向治疗提供指导模型。因此,在本综述中,我们主要关注了骨髓生态位的基本特征、物理结构和功能,并强调了它与MM细胞的相互作用。

相似文献

[1]
Multiple myeloma bone marrow niche.

Curr Pharm Biotechnol. 2009-4

[2]
Bone marrow microenvironment in multiple myeloma progression.

J Biomed Biotechnol. 2012

[3]
Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma.

Int J Hematol. 2011-10-18

[4]
Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis.

Int Rev Cell Mol Biol. 2015

[5]
The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.

Int J Mol Sci. 2021-4-24

[6]
Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma.

Oncotarget. 2016-6-21

[7]
Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma.

Eur J Haematol. 1996-11

[8]
Neovascular niche for human myeloma cells in immunodeficient mouse bone.

PLoS One. 2012-2-7

[9]
Adipose, Bone, and Myeloma: Contributions from the Microenvironment.

Calcif Tissue Int. 2017-5

[10]
The role of novel and known extracellular matrix and adhesion molecules in the homeostatic and regenerative bone marrow microenvironment.

Cell Adh Migr. 2014

引用本文的文献

[1]
CX43-mediated mitochondrial transfer maintains stemness of KG-1a leukemia stem cells through metabolic remodeling.

Stem Cell Res Ther. 2024-12-2

[2]
Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma.

Hemasphere. 2024-7-11

[3]
Cisplatin-induced oxPAPC release enhances MDSCs infiltration into LL2 tumour tissues through MCP-1/CCL2 and LTB4/LTB4R pathways.

Cell Prolif. 2024-4

[4]
Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine-Are We There Yet?

Int J Mol Sci. 2022-10-25

[5]
Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma.

Curr Oncol. 2022-11-9

[6]
Tumor-associated macrophages in multiple myeloma: advances in biology and therapy.

J Immunother Cancer. 2022-4

[7]
Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications.

Cancers (Basel). 2021-8-13

[8]
Multiple Myeloma as a Bone Disease? The Tissue Disruption-Induced Cell Stochasticity (TiDiS) Theory.

Cancers (Basel). 2020-8-4

[9]
Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment.

Blood Cancer J. 2020-6-1

[10]
Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma.

ACS Nano. 2020-4-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索